Mahzi Therapeutics
PrivateLast Round
Grant
Mar 27, 2026
Total Funding Raised
$47.79M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Mahzi Therapeutics operates in Healthcare & Life Sciences and is based in South San Francisco, California. Its latest recorded funding round was a Grant round in March 2026.
Mahzi Therapeutics is a biotechnology company that develops precision therapies for rare genetic neurodevelopmental disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mahzi Therapeutics Comparables
Compare Mahzi Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neurogene | 79% | |
| iNFixion Bioscience | 77% | |
| Capsida Biotherapeutics | 77% |
For institutional investors. Book with your work email.
Mahzi Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 27, 2026 | ||||
| Grant | Jan 30, 2025 | ||||
| Grant | Jun 27, 2024 | ||||
| Grant | Nov 29, 2022 | ||||
| Early Funding | Oct 7, 2021 | ||||
Seed | Dec 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Mahzi Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Droia Ventures | Early Funding |
| HealthCap | Early Funding |
| ArrowMark Partners | Early Funding |
| HBM Healthcare Investments | Early Funding |
| California Institute for Regenerative Medicine | Grant |
| Venrock | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 27, 2026
$8M grant from California Institute for Regenerative Medicine.
For institutional investors. Book with your work email.
Mahzi Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mahzi Therapeutics's valuation, stock price, and market status.
Is Mahzi Therapeutics a public or private company?
Mahzi Therapeutics is a private company.
What is the current stock price of Mahzi Therapeutics?
Mahzi Therapeutics is a private company, so its shares have no public market price. Caplight tracks Mahzi Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mahzi Therapeutics worth (valuation)?
Valuation information for Mahzi Therapeutics is not publicly available.
Can I buy Mahzi Therapeutics stock?
Mahzi Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mahzi Therapeutics's last funding round?
Mahzi Therapeutics's most recent funding round was Grant on March 27, 2026.
Who are the main investors in Mahzi Therapeutics?
Key investors in Mahzi Therapeutics include California Institute for Regenerative Medicine.
Will Mahzi Therapeutics IPO soon?
No public IPO plans have been announced for Mahzi Therapeutics.
How can I track Mahzi Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Mahzi Therapeutics's shares on secondary markets.